학술논문
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction
Document Type
Article
Author
Source
In: Clinical Lung Cancer . (Clinical Lung Cancer, May 2022, 23(3):e269-e272)
Subject
Language
English
ISSN
19380690
15257304
15257304